Initial treatment of Parkinson disease: levodopa or dopamine agonists.
Weiner
William J
WJ
Department of Neurology, Maryland Parkinson's Disease and Movement Disorder Center, 22 S. Greene Street, Baltimore, MD 21201-1595, USA. wweiner@som.umaryland.edu
D019468:Disease Management; D018491:Dopamine Agonists / Q000627:therapeutic use*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism
D018491:Dopamine Agonists; D018696:Neuroprotective Agents; D007980:Levodopa